Wu‐Tao Zeng
- Cardiology and Cardiovascular Medicine top 5%
- Internal Medicine top 5%
- Epidemiology
- Endocrinology, Diabetes and Metabolism
- Molecular Biology
- Topics
- Renin-Angiotensin System Studies (5 papers)Antiplatelet Therapy and Cardiovascular Diseases (2 papers)Cardiac Arrhythmias and Treatments (2 papers)
- Journals
- Journal of the American College of CardiologyStrokeBiochemical and Biophysical Research Communications
- Partner nations
- China
In The Last Decade
Wu‐Tao Zeng
18 papers receiving 580 citations
Peers
Comparison fields: 5 of 77
- Cardiology and Cardiovascular Medicine 310
- Internal Medicine 140
- Epidemiology 91
- Endocrinology, Diabetes and Metabolism 87
- Molecular Biology 82
Countries citing papers authored by Wu‐Tao Zeng
This map shows the geographic impact of Wu‐Tao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu‐Tao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu‐Tao Zeng more than expected).
Fields of papers citing papers by Wu‐Tao Zeng
This network shows the impact of papers produced by Wu‐Tao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu‐Tao Zeng. The network helps show where Wu‐Tao Zeng may publish in the future.
Co-authorship network of co-authors of Wu‐Tao Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Wu‐Tao Zeng. A scholar is included among the top collaborators of Wu‐Tao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu‐Tao Zeng. Wu‐Tao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 17 | |
| 5 | 32 | |
| 6 | 115 | |
| 7 | 48 | |
| 8 | 57 | |
| 9 | 144 | |
| 10 | 21 | |
| 11 | 59 | |
| 12 | [Angiotensin-(1-7) reduced postangioplasty vascular fibrosis in abdominal aorta of rabbits]. | 1 |
| 13 | 38 | |
| 14 | [Study on up-regulation of the expression of angiotensin-converting enzyme-2 in human umbilical vein endothelial cells by telmisartan]. | 1 |
| 15 | Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure. | 3 |
| 16 | Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats. | 16 |
| 17 | [Angiotensin-(1-7) modulates fibrinolytic imbalance induced by oxidized low-density lipoprotein in cultured human umbilical vein endothelial cells]. | 1 |
| 18 | [Effects of ACE inhibitor on the calcium transient and calcium handling proteins in ventricular myocytes from rats with heart failure]. | 1 |
About Wu‐Tao Zeng
Wu‐Tao Zeng is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pharmacology, having authored 18 papers that have together received 590 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). The work is most often cited by research in Internal Medicine (140 citations), Cardiology and Cardiovascular Medicine (310 citations) and Pharmacology (67 citations). Wu‐Tao Zeng has collaborated with scholars based in China. Frequent co-authors include Yun‐Jiu Cheng, Su‐Hua Wu, Yugang Dong, Fengjuan Yao, Zhihao Liu, Dongdan Zheng, Kai Tang, Hong Ma, Weiyan Chen and Wei‐Yi Mei. Their work appears in journals such as Journal of the American College of Cardiology, Stroke and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.